Arkolith/Insider Trading/ALT/Form 4

Gill John

DirectorAltimmune, Inc. (ALT) · full profile →Form 4 · filed Sep 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2022Gift(G)3K—$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 25, 2025Grant(A)49K—$049K

Transaction Codes

G
Gift
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-094493) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML